In fact, new approaches using intravenous BCG to stimulate certain immune populations, such as Th1/Th17 CD4 or CD8 T cells, proposed to increase TB protection in youngster or adults could benefit from the use of fractions and not viable bacteria (33). This evidence concerns the gene CD4 and tuberculosis.